Skip to content

13F-HR filed by CVI Holdings, LLC

CVI Holdings, LLC filed this 13F-HR for the quarter ended 2020-03-31, filed 2020-05-15, with 37 holding rows worth $28,478,000.

Accession
0001728194-20-000002
Filed
2020-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2020

A holdings report, 37 entries on the cover page, a total value of $28,478,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $28,478,000 with VALUE read as thousands by filing date, 13F file number 028-18767. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
TIMKENSTEEL CORP887399AA1CONVERTIBLE BOND10,455,000$8,429,000thousands by filing dateprincipal
YUNHONG INTLG98882114UNIT 99/99/9999350,000$3,325,000thousands by filing date
INOVIO PHARMACEUTICALS INC45773HAB8NOTE2,000,000$2,984,000thousands by filing dateprincipal
ENLIVEX LTDM4130Y106CMN385,621$1,805,000thousands by filing date
SENSEONICS HLDGS INC81727UAA3NOTE 5.250% 2/01,500,000$1,479,000thousands by filing dateprincipal
ADAMIS PHARMACEUTICALS CORP00547W208COM NEW3,397,916$1,214,000thousands by filing date
BAUDAX BIO INC07160F107COM432,325$1,072,000thousands by filing date
CELSION CORP15117N503COM PAR NEW1,139,110$1,030,000thousands by filing date
EROS INTL PLCG3788M114SHS NEW480,962$794,000thousands by filing date
PHIO PHARMACEUTICALS CORP71880W303COM360,094$637,000thousands by filing date
VERASTEM INC92337C104COM232,559$614,000thousands by filing date
KITOV PHARMA LTD SPONSORED ADS49803V107Stock1,977,554$605,000thousands by filing date
RESONANT INC76118L102COM405,274$600,000thousands by filing date
REPLIMUNE GROUP INC76029N106COMMON STOCK58,595$584,000thousands by filing date
POLARITYTE INC731094108COM451,240$487,000thousands by filing date
NOVAN INC66988N106COM2,914,854$435,000thousands by filing date
SAVARA INC805111101COM204,666$434,000thousands by filing date
AMYRIS INC03236M200COM NEW112,639$288,000thousands by filing date
TETRAPHASE PHARMACEUTICALS I88165N204COM NEW208,074$266,000thousands by filing date
VASCULAR BIOGENICS LTDM96883109COM181,888$246,000thousands by filing date
FARMMI INC SHS NEWG33277107Stock426,387$229,000thousands by filing date
BELLEROPHON THERAPEUTICS INC078771300COM NEW19,200$210,000thousands by filing date
CEL-SCI CORP150837607COM PAR NEW17,200$198,000thousands by filing dateput
CONTANGO OIL & GAS CO COM NEW21075N204Stock91,120$137,000thousands by filing date
REGULUS THERAPEUTICS INC75915K200COM NEW280,152$129,000thousands by filing date
SOL GEL TECHNOLOGIESM8694L103SHS10,068$71,000thousands by filing date
VERB TECHNOLOGY CO INC92337U112*W EXP 04/09/202240,000$67,000thousands by filing date
EXICURE INC30205M101COM44,798$66,000thousands by filing date
CHECK CAP LTDM2361E161*W EXP 05/03/202136,364$23,000thousands by filing date
SIGMA LABS INC826598112*W EXP 02/15/20248,100$9,000thousands by filing date
ARTELO BIOSCIENCES INC04301G128*W EXP 06/20/20265,000$4,000thousands by filing date
Plus Therapeutics Inc WTS72941H111COMMON259,200$2,000thousands by filing date
BENITEC BIOPHARMA LTD082053117*W EXP 08/14/20250,000$2,000thousands by filing date
CREATIVE REALITIES INC22530J119*W EXP 11/19/20215,000$1,000thousands by filing date
MEDIGUS LTD58471G128*W EXP 07/22/20263,286$1,000thousands by filing date
AMERI HLDGS INC WT EXP 11082302362F112Stock85,231$1,000thousands by filing date
ENERGY FUELS INC292671179*W EXP 09/277,777$0thousands by filing dateValue filed as zero, left out of ratios.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001728194-20-000002this filing2020-05-15acceptance time not in the bulk data set